| Product ID |
Product Name |
CAS# |
Purity |
| Y3297580 |
JG-23 |
2640819-75-4 |
99% |
| Y3288210 |
Influenza hemagglutinin (HA) epitope |
92000-72-1 |
98% |
| Y3272418 |
M-1211 |
2377337-93-2 |
99% |
| Y3266784 |
FGFR3-IN-5 |
2446664-72-6 |
99% |
| Y3294499 |
(Aminooxy)acetamide-Val-Cit-PAB-MMAE |
2446645-88-9 |
97% |
| Y3307546 |
IDH1 Inhibitor 7 |
2135309-56-5 |
99% |
| Y3266809 |
Nrf2 activator-2 |
2770448-53-6 |
98.92% |
| Y3293115 |
UNC7467 |
2922283-43-8 |
98% |
| Y3297241 |
eIF4A3-IN-16 |
1402931-74-1 |
95% |
| Y3291857 |
Glycodeoxycholic acid-d6 |
2483831-98-5 |
98% |
| Y3291245 |
TYA-018 |
2653254-31-8 |
98% |
| Y3118076 |
6-Chloro-3-iodoquinoline |
1416801-72-3 |
98% |
| Y3271306 |
a5ß1 integrin agonist-1 |
2756557-83-0 |
99.96% |
| Y3270948 |
BPR1R024 |
2503015-75-4 |
99% |
| Y3287451 |
DKFZ-748 |
2490709-68-5 |
98% |
| Y3118070 |
2-(4-((tert-Butoxycarbonyl)amino)phenyl)-2,2-difluoroacetic acid |
2228368-99-6 |
98% |
| Y3270487 |
Emprumapimod |
765914-60-1 |
99.12% |
| Y3310762 |
JAK-IN-24 |
2042629-43-4 |
98% |
| Y3267341 |
HKB99 |
2414908-90-8 |
97.35% |
| Y3287536 |
PROTAC BRD9 Degrader-6 |
2676211-62-2 |
98% |
| Y3266990 |
(Rac)-BIO8898 |
402564-79-8 |
99.81% |
| Y3287693 |
JB002 |
30408-07-2 |
99% |
| Y3310877 |
6-Formyl-isoophiopogonanone B |
88700-30-5 |
98% |
| Y3307231 |
(Rac)-Ruxolitinib-d8 |
1794791-38-0 |
99% |
| Y3267400 |
Rolusafine |
2089153-78-4 |
98.78% |
| Y3265361 |
RAGE 229 |
2143072-85-7 |
99% |
| Y3306846 |
1-Bromo-3-fluoro-2-methyl-5-(trifluoromethyl)benzene |
2167191-11-7 |
95% |
| Y3314936 |
(S)-7-Bromochroman-4-amine |
1213134-75-8 |
99% |
| Y3286979 |
KTX-951 |
2573298-36-7 |
98% |
| Y3310326 |
Epiboxidine hydrochloride |
862909-67-9 |
99% |
| Y3307149 |
(Rac)-Bedaquiline-d6 |
2517573-53-2 |
95% |
| Y3113759 |
(6-Bromo-4-chloropyridin-2-yl)methanol |
1806839-26-8 |
97% |
| Y3267254 |
Fmoc-N(Me)-Sar10 |
2375600-56-7 |
97.11% |
| Y3271307 |
Thiamphenicol-d3 |
2211914-19-9 |
95% |
| Y3271443 |
Bicyclo[2.2.0]hexane-1-carboxylic acid |
79368-50-6 |
95% |
| Y3271199 |
2-Azabicyclo[2.1.1]hexan-4-ol hydrochloride |
2411194-59-5 |
95% |
| Y3266194 |
DS89002333 |
2832159-79-0 |
99% |
| Y3118060 |
tert-Butyl (2,5-difluoropyridin-4-yl)carbamate |
1803125-70-3 |
95% |
| Y3294350 |
CZL55 |
667408-87-9 |
98% |
| Y3104861 |
PKI (14-24)amide TFA |
1293946-39-0 |
98% |
| Y3292352 |
ß-Carotene-d8 |
53163-44-3 |
96% |
| Y3118066 |
Bis[(tetrabutylammonium iodide)copper(I) iodide] |
81412-07-9 |
98% |
| Y3104961 |
eIF4A3-IN-9 |
1402931-71-8 |
99% |
| Y3308893 |
Complanatin I |
138505-45-0 |
98% |
| Y3105012 |
tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate |
156865-72-4 |
95% |
| Y3105013 |
1-(Fluoromethyl)-2-oxabicyclo[2.1.1]hexane-4-carboxylic acid |
2253631-32-0 |
95% |
| Y3291862 |
Pitavastatin-d5 sodium |
2747917-94-6 |
95% |
| Y3105125 |
DC-LC3in-D5 |
2868312-73-4 |
98.51% |
| Y3285989 |
Methyl 5-methoxy-1h-pyrrolo[2,3-b]pyridine-2-carboxylate |
1260385-39-4 |
95% |
| Y3295443 |
Zelicapavir |
2070852-76-3 |
98% |
| Y3118073 |
ISX-3 |
912789-08-3 |
98% |
| Y3266702 |
4-Bromo-1,2-dimethyl-1H-pyrrolo[2,3-b]pyridine |
1415928-59-4 |
95% |
| Y3288903 |
Exatecan-amide-cyclopropanol |
2414254-34-3 |
98% |
| Y3262236 |
EG-011 |
2377113-41-0 |
98.77% |
| Y3294466 |
MS8815 |
2855085-25-3 |
99% |
| Y3294415 |
NADPH oxidase-IN-1 |
2762405-17-2 |
99% |
| Y3306801 |
Adrixetinib |
2394874-66-7 |
99% |
| Y3261012 |
STAT3-IN-13 |
2248552-86-3 |
99% |
| Y3272758 |
S1R agonist 2 |
150085-21-5 |
98.0% |
| Y3268670 |
ARUK2001607 |
2924824-56-4 |
99% |
| Y3293051 |
JAK-IN-25 |
2127110-22-7 |
98% |
| Y3259521 |
RYL-552S |
1801444-69-8 |
98% |
| Y3306668 |
MC-PEG2-NH2 |
640267-62-5 |
98% |
| Y3289968 |
Thymidine-5'-diphosphate-L-rhamnose disodium |
214753-67-0 |
98% |
| Y3266497 |
SERT-IN-2 |
2055228-33-4 |
98% |
| Y3311810 |
[1,1'-Biphenyl]-4,4'-diyldimethanamine |
2457-28-5 |
95% |
| Y3296890 |
Se-DMC |
2098850-81-6 |
98% |
| Y3286382 |
HIV-1 inhibitor-45 |
2677762-43-3 |
99% |
| Y3113807 |
3-Methyl-2-(2-(trifluoromethyl)phenyl)butanoic acid |
1225487-35-3 |
98% |
| Y3315179 |
1,3-Dioxoisoindolin-2-yl 4-fluorobenzoate |
305359-06-2 |
98% |
| Y3293820 |
Maytansinoid B |
1628543-40-7 |
95% |
| Y3287614 |
(3,5-Dichlorophenyl)glycine |
42288-29-9 |
95% |
| Y3259851 |
BAY-204 |
2468784-57-6 |
98.87% |
| Y3114404 |
PARP10-IN-3 |
2225800-19-9 |
98% |
| Y3290588 |
STING agonist-22 |
2408723-12-4 |
99% |
| Y3296263 |
WS-898 |
2891562-77-7 |
98% |
| Y3268499 |
OPN expression inhibitor 1 |
2257492-95-6 |
96.99% |
| Y3271605 |
IMP2-IN-2 |
1448353-39-6 |
99% |
| Y3288023 |
CB1/2 agonist 3 |
2772655-86-2 |
99% |
| Y3114300 |
PTP1B-IN-22 |
86109-60-6 |
98% |
| Y3296096 |
Anti-amyloid agent-1 |
1396778-73-6 |
99% |
| Y3298130 |
2-Methyl-3-(methylthio)propanenitrile |
1183030-38-7 |
95% |
| Y3295767 |
NNZ 2591 |
847952-38-9 |
99% |
| Y3289113 |
UZH2 |
2756566-45-5 |
98% |
| Y3271224 |
LSN3318839 |
2764704-18-7 |
97% |
| Y3296131 |
CCG273441 |
2750414-35-6 |
98% |
| Y3259416 |
KIF18A-IN-7 |
2914878-00-3 |
98.09% |
| Y3264220 |
STAT3-IN-11 |
2503096-50-0 |
98% |
| Y3287443 |
(R)-Casopitant |
414910-26-2 |
98% |
| Y3309978 |
Ac-IHIHIQI-NH2 |
1582727-85-2 |
99% |
| Y3309311 |
Quercetin-3-O-sophoroside-7-O-glucoside |
42903-93-5 |
94% |
| Y3264867 |
PD-1/PD-L1-IN-14 |
2499965-12-5 |
99.85% |
| Y3264586 |
Enpp-1-IN-16 |
2289739-47-3 |
99% |
| Y3309128 |
GPR41 agonist-1 |
506417-09-0 |
98% |
| Y3267450 |
MrgprX2 antagonist-1 |
2642162-06-7 |
99.93% |
| Y3267771 |
MPP hydrochloride |
2863676-89-3 |
99% |
| Y3262407 |
MMV688845 |
2208962-35-8 |
99% |
| Y3290234 |
Mal-PEG3-NH2 TFA |
2830214-77-0 |
98% |
| Y3259976 |
PROTAC CYP1B1 degrader-1 |
2411389-67-6 |
98% |
| Y3254410 |
POLA1 inhibitor 1 |
2217671-41-3 |
98% |